D
Zevra Therapeutics, Inc. ZVRA
$8.31 $0.374.66%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -7.57% -66.75% -19.87% 16.44% -91.88%
Total Depreciation and Amortization 1.92% 3.52% 0.00% 98.48% 1,169.35%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 65.29% 1,874.93% 172.52% -117.44% 363.85%
Change in Net Operating Assets -1,913.81% 83.40% -872.97% 94.18% -132.76%
Cash from Operations 10.42% 5.07% -18.21% -0.04% -249.14%
Capital Expenditure -- -- -- -- 58.14%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 82.55% -24,205.43% -100.87% -63.97% 192.72%
Cash from Investing 82.55% -24,205.43% -100.87% 39.75% 123.81%
Total Debt Issued -- -100.00% -- -- -86.04%
Total Debt Repaid -- 100.00% -- -- -2,407.80%
Issuance of Common Stock -98.77% 13,392.71% -60.56% -80.07% 11,418.87%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- 100.00% -- -- --
Cash from Financing -98.77% 322.47% 1,159.65% -75.68% -80.94%
Foreign Exchange rate Adjustments 236.66% -253.92% 808.89% -112.89% 442.16%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -237.05% 511.79% -1,694.50% 9.09% 99.04%
Weiss Ratings